Stock GUFICBIO GUFIC BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Gufic Biosciences Limited

Equities

GUFICBIO

INE742B01025

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-05-06 am EDT 		5-day change 1st Jan Change
326.4 INR +1.54% Intraday chart for Gufic Biosciences Limited -0.38% +3.47%
Apr. 25 Gufic Biosciences Limited Approves Reconstitution of Various Committees CI
Apr. 04 Gufic Biosciences Forms New Wholly-Owned Arm in Dubai MT

Business Summary

Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates through the pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.

Number of employees: 1,628

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical and Related Products
100.0 %
7,792 100.0 % 6,906 100.0 % -11.36%

Sales per region

INR in Million2022Weight2023Weight Delta
India
84.5 %
7,070 90.7 % 5,837 84.5 % -17.44%
Asia
7.4 %
281 3.6 % 512 7.4 % +81.92%
Europe
4.3 %
255 3.3 % 294 4.3 % +15.29%
Africa
1.9 %
91 1.2 % 134 1.9 % +47.58%
North America
1.7 %
84 1.1 % 116 1.7 % +39.09%
South America
0.1 %
6 0.1 % 8 0.1 % +20.12%
Australia
0.1 %
4 0.1 % 5 0.1 % +31.86%

Managers

Managers TitleAgeSince
Pranav Jayesh Choksi CEO
 Chief Executive Officer 41 04-06-24
Jayesh Pannalal Choksi CEO
 Chief Executive Officer - 99-08-30
Devkinandan Banwaril Roonghta DFI
 Director of Finance/CFO - 18-10-28
Nagesh Yarrabathina COO
 Chief Operating Officer - 19-07-31
Ami Naresh Shah CMP
 Compliance Officer - 16-03-21
Avik Das IRC
 Investor Relations Contact - -
Sunil Desai HRO
 Human Resources Officer - -
Hemal Milan Desai AUD
 Comptroller/Controller/Auditor - -
Rasik Vasudev Kulkarni SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Jayesh Pannalal Choksi CEO
 Chief Executive Officer - 99-08-30
Pranav Jayesh Choksi CEO
 Chief Executive Officer 41 04-06-24
Pankaj Jaykumar Gandhi BRD
 Director/Board Member 64 86-12-31
Shreyas Kantilal Patel BRD
 Director/Board Member 61 14-09-25
Gopal M. Daptari BRD
 Director/Board Member 74 17-09-04
Balram H. Singh BRD
 Director/Board Member 65 18-05-28
Rabi Narayan Sahoo BRD
 Director/Board Member - 19-06-28
Anu Sanjiv Aurora BRD
 Director/Board Member - 19-12-22
Dilip B. Ghosh BRD
 Director/Board Member 71 20-11-11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 100,277,506 22,401,555 ( 22.34 %) 0 22.34 %

Shareholders

NameEquities%Valuation
Jayesh Pannalal Choksi
24.62 %
24,690,829 24.62 % 84 M ₹
Zircon Teconica Pvt Ltd.
20.47 %
20,523,330 20.47 % 70 M ₹
Gufic Pvt Ltd.
10.16 %
10,191,523 10.16 % 35 M ₹
Vipula Jayesh Choksi
10.01 %
10,033,843 10.01 % 34 M ₹
Pranav Jayesh Choksi
7.249 %
7,268,626 7.249 % 25 M ₹
Jagdish N Master
1.788 %
1,793,000 1.788 % 6 M ₹
Motilal Oswal Asset Management Co. Ltd.
1.046 %
1,049,031 1.046 % 4 M ₹
SBI Funds Management Ltd.
0.9972 %
1,000,000 0.9972 % 3 M ₹
Gulati Girish Family
0.9701 %
972,800 0.9701 % 3 M ₹
Government of India
0.2438 %
244,506 0.2438 % 830 093 ₹

Company contact information

Gufic Biosciences Ltd.

S. M. House 11 Sahakar Road

400057, Mumbai

+91 22 6726 1000

http://www.gufic.com
address Gufic Biosciences Limited(GUFICBIO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
GUFIC BIOSCIENCES LIMITED Stock Gufic Biosciences Limited
+3.47% 387M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.90% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+4.60% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.59% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GUFICBIO Stock
  4. Company Gufic Biosciences Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW